Thymalin is a polypeptide complex extracted from calf thymus that was developed in Russia for immunomodulatory therapy. It contains a mixture of peptides that influence T-lymphocyte function and immune system regulation. Thymalin has been used clinically in Russia since the 1970s for immunodeficiency conditions, infection prevention, and as an adjunct in cancer treatment. The peptide complex helps restore immune function in immunocompromised individuals by promoting T-cell maturation and differentiation. Thymalin also demonstrates anti-aging effects related to immune system restoration and has been studied in geroprotection research.
| Research Status | Approved in Russia |
|---|---|
| Half-Life | Variable |
| Administration | Intramuscular injection |
| Typical Dosage | 10 mg daily |
| Molecular Weight | Variable (peptide complex) |
| Molecular Formula | Variable (complex mixture) |
Complex of thymic peptides that restore immune function and thymus activity.
All information is presented for Research Use Only (RUO). Not medical advice.